Clinical obesity
| Clinical obesity |
| Pubbl/distr/stampa | Oxford, UK, : Wiley-Blackwell |
| Soggetto topico |
Obesity - Treatment
Obesity Obesitat |
| Soggetto genere / forma |
Periodical
Revistes electròniques. |
| ISSN | 1758-8111 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910216943803321 |
| Oxford, UK, : Wiley-Blackwell | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current obesity reports
| Current obesity reports |
| Pubbl/distr/stampa | [Philadelphia, PA], : Current Medicine Group, 2012- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Obesity
Endocrinologia Obesitat |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| ISSN | 2162-4968 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910307933803321 |
| [Philadelphia, PA], : Current Medicine Group, 2012- | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors
| Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (262 pages) |
| Disciplina | 615.321 |
| Soggetto topico |
Phytochemicals - Health aspects
Fitoquímica Nutrició Biotransformació (Metabolisme) Càncer Obesitat Diabetis |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-72999-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Etiology of Obesity, Cancer, and Diabetes -- 1 Introduction -- 2 Obesity -- 2.1 Etiology of Obesity -- 2.2 Biological Factors -- 2.2.1 Genetics -- Monogenic Obesity -- Syndromic Obesity -- Polygenic Obesity -- 2.2.2 Brain-gut Axis -- 2.2.3 Prenatal Determinants -- 2.2.4 Pregnancy -- 2.2.5 Menopause -- 2.2.6 Physical Disability -- 2.2.7 Gut Microbiome -- 2.3 Environmental Factors -- 2.3.1 Obesogenic Environment -- 2.3.2 Socio-Economic Factors -- 2.3.3 Environmental Chemicals and Obesity -- 2.4 Behavioral Factors -- 2.4.1 Increased Calorie Intake and Eating Habits -- 2.4.2 Sedentary Lifestyle and Less Physical Activity -- 2.4.3 Insufficient Sleep -- 2.4.4 Quitting Smoking -- 3 Cancer -- 3.1 Major Types of Cancer -- 3.2 Causes of Cancer -- 3.2.1 Diet and Physical Activity -- 3.2.2 Use of Addictive Substances -- 3.2.3 Sex and Reproductive Health -- 3.2.4 Environmental Factors -- 3.2.5 Genetics -- 4 Diabetes Mellitus -- 4.1 Causes of Type 1 Diabetes Mellitus -- 4.1.1 Genetic Susceptibility Factors -- 4.1.2 Virus-Related Contagions -- 4.1.3 Role of Environment -- 4.2 Etiology of Type 2 Diabetes Mellitus -- 5 Conclusion -- References -- Pathophysiology of Obesity and Diabetes -- 1 Introduction -- 2 Obesity and Body Mass Index -- 3 Pathophysiology of Obesity -- 3.1 Development of Fat Cells -- 3.2 Fat Cell Metabolism -- 3.3 Oxidative Stress -- 3.4 Weight Stigma -- 4 Role of Different Factors in the Pathophysiology of Obesity -- 4.1 Pathophysiology of Obesity and the Role of Autonomic Nervous System -- 4.2 Osteopontin and Obesity -- 4.3 Obesity and Renal Disease -- 5 Maternal Obesity -- 6 Potential Role of Gut Inflammation in Disease Development -- 7 Childhood Obesity -- 8 Pathophysiology of Diabetes -- 8.1 Etiology of Diabetes -- 8.2 Role of Genetics in Development of T2DM.
8.3 Role of Environmental Determinants in the Development of T2DM -- 8.4 Insulin Resistance -- 8.5 The Role of Glucagon -- 8.6 Somatostatin -- 9 Conclusion -- References -- Pathophysiology of Obesity and Cancer: Drugs and Signaling Targets -- 1 Introduction -- 2 Pathophysiology of Obesity and Cancer -- 3 History of Anti-obesity Drugs -- 4 How to Treat Obesity? -- 5 Different Targets in Brain to Treat Obesity -- 5.1 Serotoninergic System -- 5.2 Noradrenergic System -- 5.3 Dopaminergic System -- 6 Link Between Obesity and Cancer -- 7 Drugs Targeting Cancer Cells -- 8 Drugs Targeting the Tumor Microenvironment's Cellular and Molecular Components -- 9 Changes in the Pharmacokinetics -- 10 Changes in Microbiota -- 11 Combination Therapy -- 12 Conclusion -- References -- Peptides Involved in Body Weight Regulation -- 1 Introduction -- 2 Appetite, Food Intake, and Obesity -- 3 Peptides and Body Weight -- 3.1 Effects of Hormonal Peptides -- 3.1.1 Orexigenic Peptides -- 3.1.2 Anorexigenic Peptides -- 3.1.3 Effects of Hypothalamic Peptides -- 3.2 Bioactive Peptides and Body Weight -- 4 Conclusion -- References -- Insulin Resistance: A Link Between Obesity and Cancer -- 1 Introduction -- 2 Obesity and Cancer -- 3 Diabetes and Cancer -- 4 Obesity and Diabetes -- 5 Mechanism Linking Insulin Resistance to Obesity and Cancer -- 6 Drugs to Treat Insulin Resistance -- 6.1 Metformin -- 6.2 Thiazolidinediones -- 6.3 Insulin Analogues -- 7 Challenges in Prevention and Treatment -- 8 Conclusion -- References -- Role of Cytoskeletal Protein, Actin in Various Diseases -- 1 Introduction -- 2 Microfilaments or Actin Filaments -- 2.1 Role in Cancer Metastasis and Tumor Angiogenesis -- 2.2 Role in Cytokinesis -- 2.3 Role in Cellular Signaling and Transport -- 2.4 Role in Immunodeficiency -- 2.5 Role in Fertilization of Eggs -- 2.6 Role in Neuronal Plasticity. 2.7 Role in Neurodegenerative Diseases -- 2.8 Role in Epigenetic Control -- 2.9 Role in Muscle Contraction -- 3 Conclusions -- References -- Diabetes Mellitus and it Management with Plant-Based Therapy -- 1 Introduction -- 2 Classification of Diabetes -- 2.1 Type I Diabetes Mellitus (T1DM) -- 2.2 Type II Diabetes Mellitus (T2DM) -- 2.3 Gestational DM (GDM) -- 3 Risk Factors of Diabetes -- 4 Pathophysiology -- 5 Screening and Diagnosis -- 6 Management -- 6.1 Through Lifestyle and Diet Modification -- 6.2 Pharmacological Agents -- 6.3 Plant Based Therapy -- 6.3.1 Mechanisms Underlying Herbal Anti-Diabetic Therapies -- 6.3.2 Classification of Plant-Based Anti-Diabetics -- 7 Conclusion -- References -- Fruits and Vegetables as Sources of Functional Phytochemicals for the Prevention and Management of Obesity, Diabetes, and Cancer -- 1 Introduction -- 2 Classification of Phytochemicals -- 2.1 Polyphenols -- 2.2 Terpenoids -- 2.3 Thiols -- 3 Health Benefits and Nutritional Value of Certain Fruits and Vegetables -- 3.1 Tomatoes -- 3.2 Grapes and Berries -- 3.3 Nuts -- 3.4 Citrus -- 3.5 Brassica Vegetables -- 3.6 Mushrooms -- 3.7 Kiwi -- 3.8 Cladodes -- 3.9 Carrots -- 3.10 Potatoes -- 3.11 Onion and Garlic -- 4 The Effect of Consuming Fruits and Vegetables on Some Diseases -- 4.1 Cancer -- 4.2 Obesity -- 4.3 Diabetes -- 5 Conclusion -- References -- Spices for Diabetes, Cancer and Obesity Treatment -- 1 Introduction -- 2 Anti-diabetic Effect of Spices -- 2.1 Fenugreek -- 2.2 Cinnamon -- 2.3 Garlic and Onion -- 2.4 Turmeric -- 2.5 Cumin Seeds -- 2.6 Ginger -- 3 Spices in the Treatment of Cancer -- 3.1 Basil -- 3.2 Caraway -- 3.3 Cardamom -- 3.4 Rosemary -- 3.5 Cumin -- 3.6 Turmeric -- 3.7 Garlic -- 3.8 Black Pepper -- 3.9 Red Chili -- 3.10 Ginger -- 3.11 Saffron -- 4 Spices in the Treatment of Obesity -- 4.1 Ginger -- 4.2 Turmeric -- 4.3 Garlic. 4.4 Red Pepper -- 5 Conclusion -- References -- MicroRNAs as Targets of Dietary Phytochemicals in Obesity and Cancer -- 1 Introduction -- 2 Phytochemical Modulated miRNAs and Its Role in Obesity -- 3 MicroRNAs as Phytochemicals Targets in Carcinogenesis -- 4 Dietary Phytochemicals and miRNA -- 4.1 Resveratrol -- 4.2 Genistein -- 4.3 Conjugated Linoleic Acids -- 4.4 Cinnamic Acid and Cinnamaldehyde -- 4.5 Ajoene -- 4.6 Curcumin -- 4.7 Epigallocatechin-3-Gallate -- 4.8 Quercetin -- 5 Conclusion -- References -- Natural Phenolic Compounds as Anti-obesity and Anti-cardiovascular Disease Agent -- 1 Introduction -- 2 Effects of Natural Phenolic Compounds on Oil and Fat Metabolism -- 3 Binding Bile Salt to Inhibit Emulsification of Lipids -- 3.1 In Vitro Studies -- 4 Pancreatic Lipase Inhibition -- 4.1 In Vitro Studies -- 4.2 In Silico Modeling Studies -- 4.3 Increase Fecal Lipid Excretion -- 4.4 Animal Models -- 4.5 Clinical Research -- 5 Gut Microbiota as Potential Targets -- 6 Reduction of Lipogenesis and Inflammation in Adipose Tissue and Liver -- 6.1 In Vitro Studies by Cell Models -- 6.2 Animal Models -- 7 Suppression of Lipogenic Enzyme Fatty Acid Synthase (FAS) in Cell -- 7.1 Cell Model -- 7.2 Animal Models -- 8 Increase of Lipolysis in Cell -- 9 Inhibition of Adipocyte Differentiation and Growth -- 10 Anti-atherosclerosis by Natural Phenolic Compounds -- 11 Conclusion -- References -- Harnessing the Potential of Phytochemicals for Breast Cancer Treatment -- 1 Introduction -- 2 Statistical Evidence Including the Indian Scenario -- 3 Current Treatments Strategies for Breast Cancer -- 3.1 Chemotherapy -- 3.2 Surgery -- 3.3 Gene Therapy -- 3.4 Oncogenes Inactivation -- 3.5 Augmentation of Tumor Suppresser Genes -- 3.5.1 BRCA1 and BRCA2 -- 3.5.2 Androgen Receptor -- 3.5.3 Immunomodulation -- 3.5.4 Endocrine (Antihormonal) Treatment. 3.5.5 Inclination Towards Phytochemicals -- 4 Phytochemicals for Breast Cancer Therapy -- 4.1 Plumbagin -- 4.2 Apigenin -- 4.3 Isothiocyanate -- 4.4 Quercetin -- 4.5 Curcumin -- 4.6 Catechins -- 4.7 Lycopene -- 4.8 Hesperidin -- 4.9 Anthocyanin -- 4.10 Colchicine Alkaloid -- 4.11 Polyphyllin D -- 4.12 Genistein -- 4.13 Resveratrol -- 4.14 Berberine -- 5 Pharmaceutical Compounding of Phytochemicals -- 6 Conclusion -- References -- Index. |
| Record Nr. | UNINA-9910495214003321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Eating and weight disorders : studies on anorexia, bulimia and obesity
| Eating and weight disorders : studies on anorexia, bulimia and obesity |
| Pubbl/distr/stampa | Milano, Italy : , : Editrice Kurtis, , 1996- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Eating disorders
Body weight Obesity Leanness Body Weight Feeding and Eating Disorders Emaciation Troubles du comportement alimentaire Poids corporel Obésité Émaciation Obesitat Trastorns de la gana Bulímia Anorèxia nerviosa |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals Periodicals. Périodiques. Revistes electròniques |
| ISSN | 1590-1262 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | EWD |
| Record Nr. | UNINA-9910307934403321 |
| Milano, Italy : , : Editrice Kurtis, , 1996- | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The economics of obesity : poverty, income inequality, and health / / Tahereh Alavi Hojjat
| The economics of obesity : poverty, income inequality, and health / / Tahereh Alavi Hojjat |
| Autore | Hojjat Tahereh Alavi <1953-> |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (178 pages) |
| Disciplina | 362.196398 |
| Soggetto topico |
Obesity - Economic aspects
Obesitat Condicions econòmiques Desigualtat social Pobresa |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-78487-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- References -- Preface -- References -- Acknowledgments -- Contents -- About the Author -- Abbreviations -- List of Figures -- List of Tables -- Chapter 1: Introduction: The Magnitude of the Obesity Problem -- The Magnitude of the Obesity Problem -- References -- Chapter 2: Different Perspectives on Causes of Obesity -- References -- Chapter 3: Consequences of Obesity -- References -- Chapter 4: Economic Analysis: Behavioral Patterns, Diet Choice, and the Role of Government -- Rational Obesity Model -- An Alternative Model -- References -- Chapter 5: Socioeconomic Factors: Poverty and Obesity -- Income Inequality and Health -- References -- Chapter 6: Income and Wealth Inequality and Obesity -- Measure and Sources of Inequality -- References -- Chapter 7: Data and Methodology: Empirical Investigation of the Relationship Among Obesity, Income Inequality, and Poverty -- Model and Methodology -- Specification of the Model -- Methodology -- Results Discussion -- Causality Test -- Appendix -- References -- Chapter 8: Obesity and Socioeconomic Status: Case Study of Peruvian Women -- Poverty, Inequality, and Obesity in Peru -- Model to Test Income Inequality, Poverty, and Obesity in Peru -- Model and Methodology -- Result Discussion -- Causality Test -- Concluding Comments -- Appendix: Supplemental Tables and Figures -- References -- Chapter 9: Social Mobility and Health -- Defining Social Mobility -- Income Inequality and Social Mobility -- Intergenerational Mobility -- Income Inequality and Social Mobility Among Different Racial and Ethnic Groups -- Poverty, Education, and Economic Mobility -- Wealth and Economic Mobility -- Effect of Income on Health and Social Mobility -- References -- Chapter 10: Food Policies, Government Interventions, and Reducing Poverty -- Menu Labeling.
Taxation, Subsidization, and Role of Income Inequality -- Reducing Poverty, Learning Gap, and Access to Healthy Food in Low-Income Areas -- Food Advertising Regulation and the Roles of Technology -- References -- Chapter 11: Concluding Comments -- References -- Glossary of Terms -- Index. |
| Record Nr. | UNINA-9910495351703321 |
Hojjat Tahereh Alavi <1953->
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Food addiction, obesity, and disorders of overeating : an evidence-based assessment and clinical guide / / Claire E. Wilcox
| Food addiction, obesity, and disorders of overeating : an evidence-based assessment and clinical guide / / Claire E. Wilcox |
| Autore | Wilcox Claire E. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (224 pages) |
| Disciplina | 616.8526 |
| Soggetto topico |
Compulsive eating
Trastorns de la conducta alimentària Trastorns de la gana Obesitat |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-83078-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Introduction: Obesity, Eating Disorders and Food Addiction: Towards a Synthesis -- References -- Contents -- Contributors -- Part I: Standard Approaches to Clinical Assessment and Treatment of Obesity and Binge Eating Disorder (BED) -- 1: Determinants of Body Weight: Metabolism and the Homeostatic System -- 1.1 Energy Balance -- 1.2 Metabolism -- 1.3 Why Weight Gain Is So Easy and Weight Loss So Hard -- 1.4 Homeostatic Feeding Mechanisms -- 1.4.1 The Hypothalamus -- 1.4.2 Key Neuropeptides -- 1.4.3 Other Factors -- 1.5 Neuropeptides, Obesity, and Disordered Eating -- 1.6 Conclusion -- References -- 2: Obesity -- 2.1 Definition of Obesity -- 2.2 Epidemiology -- 2.3 Assessment -- 2.4 Causes, Contributors, and Risk Factors -- 2.5 Genetics -- 2.6 Management -- 2.6.1 Overview of Treatment -- 2.6.2 Comprehensive Models and Behavioral Weight Loss Therapy -- 2.6.3 Dietary Component -- 2.6.4 Physical Activity Component -- 2.6.5 Behavioral Modification Component -- 2.6.6 Pharmacotherapy -- 2.6.7 Dietary Supplements and Procedures to Avoid -- 2.6.8 Bariatric Surgery -- 2.7 Conclusion -- References -- 3: Binge-Related Eating Disorders (Binge Eating Disorder and Bulimia Nervosa) -- 3.1 Epidemiology -- 3.2 Diagnosis and Assessment of BED -- 3.3 Epidemiology of BN -- 3.4 Diagnosis and Assessment of BN -- 3.5 Etiology and Mechanisms of BED and BN -- 3.6 Treatment of BED: General Considerations -- 3.7 Psychotherapies for BED -- 3.8 Pharmacotherapy for BED -- 3.9 Nutritional Recommendations for BED -- 3.10 Best Practices and Guidelines for BED Treatment -- 3.11 Obesity and BED Treatment -- 3.12 Treatment of BN -- 3.13 Treatments for both BED and BN -- 3.14 Conclusion -- References -- Part II: Can the Food Addiction Concept Improve Treatment? -- 4: Problems with Current Approaches to Treating Disorders of Overeating.
4.1 Weight Loss with Available Treatments Is Modest -- 4.2 Maintenance of Weight Loss Is Difficult -- 4.3 The Biology Behind the Difficulty of Weight Loss and Maintenance -- 4.4 Eating Disorder (ED) Treatment Success Rates -- 4.5 ED and Obesity Treatments Give Conflicting Messages -- 4.6 Side Effects of Diets -- 4.7 Limitations and Side Effects of Medications -- 4.8 Side Effects of Bariatric Surgery -- 4.9 Difficulty of Exercising When Obese -- 4.10 Conclusion -- References -- 5: The Food Addiction Concept: History, Controversy, Potential Pitfalls, and Promises -- 5.1 History -- 5.2 Is the FA Concept Valid? -- 5.2.1 Can Obesity Be Explained by FA? -- 5.2.2 Is FA Distinct from BED and Bulimia? -- 5.2.3 Do DSM Criteria for SUD Present in Relation to Food in Humans and Do Symptoms Cluster Together? -- 5.2.4 Is It Valid to Claim Certain Foods Are "Addictive," and Might It Be More Accurate to Consider FA a Behavioral Disorder? -- 5.3 Is the FA Model Useful, and Do Benefits Outweigh Harms? -- 5.3.1 Abstinence-Based Food Plans -- 5.3.2 Self-Efficacy -- 5.3.3 Public Health -- 5.3.4 Stigma -- 5.4 Potential Promises for the Future -- 5.5 Increasing Community Acceptance -- 5.6 Conclusion -- References -- Part III: Clinical Evidence for Food Addiction -- 6: Clinical Evidence for the Validity of Food Addiction -- 6.1 Shared DSM Criteria -- 6.2 Yale Food Addiction Scale Development -- 6.3 SUD and Disordered Eating Co-occur -- 6.4 Sweet Preference, Addiction Transfer, and Cross-Sensitization -- 6.5 Overlapping Neuropsychological, Emotional, and Personality Traits, Psychiatric Diagnoses, and Predisposing Conditions (Trauma and Stress) -- 6.6 Conclusion -- References -- Part IV: Basic Biology of Food Addiction, and Its Overlap with Substance Use Disorders -- 7: Neurobiology and Cognitive Neuroscience of Substance Use Disorders. 7.1 Overview of Substance Use Disorders -- 7.2 Core Brain Regions -- 7.3 Reward -- 7.4 Conditioning: Positive Reinforcement -- 7.5 Motivation: Positive Reinforcement -- 7.6 Tolerance: Downregulation of Dopamine and Opioid System -- 7.7 Withdrawal and Hyperkatifeia -- 7.8 Conditioning and Motivation: Negative Reinforcement -- 7.9 Impulsivity and Executive Function Deficits -- 7.10 Benefits of Understanding the Neurobiology -- 7.11 Conclusion -- References -- 8: Neurobiology and Cognitive Neuroscience of Hedonic Eating -- 8.1 Reward and Hedonic Liking -- 8.2 Conditioning: Positive Reinforcement -- 8.3 Motivation: Positive Reinforcement -- 8.4 Food Reward, Conditioning, and Reward Motivation: Additional Factors -- 8.5 Tolerance and Downregulation of DA and Opioid Systems -- 8.6 Withdrawal -- 8.7 Conditioning and Motivation: Negative Reinforcement -- 8.8 Impulse Control and Executive Function Deficits -- 8.9 Conclusion -- References -- 9: Additional Biological Mechanisms of Hedonic Eating -- 9.1 Interactions Between the Homeostatic System and Hedonic System -- 9.1.1 Anatomy -- 9.1.2 Appetite-Regulating Neuropeptides Modulate Hedonic Eating -- 9.1.3 Appetite-Regulating Neuropeptides Moderate Drug and Alcohol Use -- 9.2 Stress, Hedonic Eating, and the Reward System -- 9.2.1 The Anatomy of the Stress Response -- 9.2.2 Acute and Chronic Stress Promote Hedonic Eating -- 9.3 Genetics -- 9.4 In Utero Exposure -- 9.5 Neuroinflammation -- 9.6 Oxidative Stress -- 9.7 Gut Microbiome and Gut-Brain Axis -- 9.8 Adrenergic System -- 9.9 Sleep and Circadian Rhythm -- 9.10 Serotonin System -- 9.11 Endocannabinoid System -- 9.12 Functional Connectivity -- 9.13 Conclusions -- References -- 10: Treatment-Related Evidence that Food Addiction Is a Valid Construct -- 10.1 Pharmacotherapy-Related Evidence -- 10.1.1 Stimulants. 10.1.2 Opioid Antagonists -- 10.1.3 Topiramate and Zonisamide -- 10.1.4 GLP-1 Agonists -- 10.1.5 Other Medications to Note -- 10.2 Bariatric Surgery -- 10.3 Conclusion -- References -- 11: Highly Palatable Foods Are Addictive -- 11.1 Problematic and "Addictive" Foods -- 11.2 Association Between HP Food Intake and Addiction in Animal Models -- 11.3 Association Between HP Food Intake and Weight Gain/Disordered Eating in Humans -- 11.4 Why Are HP Foods More Associated with Addictive Eating Patterns? -- 11.4.1 Innate Preferences -- 11.4.2 Conditioning from Rapid Post-oral Glucose Rise -- 11.4.3 Stimulation of Reward System by HP Foods -- 11.4.4 Effects on Inflammatory Processes, Oxidative Stress and Gut Microbiome -- 11.4.5 Cessation Leads to Withdrawal -- 11.4.6 Adverse Effects on Mood and Anxiety -- 11.4.7 Reduction in Executive Function -- 11.4.8 Reduction in Satiety Due to Changes in Homeostatic Feeding -- 11.4.9 Individual Variability -- 11.4.10 Feeding Patterns Influence Food Addiction -- 11.5 State Effects of Hunger/Food Restriction on Reward Circuitry and Brain Function -- 11.6 Artificial Sweeteners and Sugar Substitutes -- 11.7 What Should Be Considered Addictive Food? -- 11.8 Conclusion -- References -- Part V: Assessment and Treatment of Food Addiction -- 12: Evaluation of Food Addiction: Importance, Epidemiology, Diagnosis, and Assessment -- 12.1 Importance of Assessing for Food Addiction -- 12.2 Epidemiology of FA -- 12.3 YFAS: Scoring and Interpretation -- 12.4 Other Important Assessment Considerations and Common Comorbidities -- 12.4.1 SUD -- 12.4.2 ED History -- 12.4.3 Obesity History and Related Health Concerns -- 12.4.4 Psychiatric Comorbidity -- 12.5 Conclusion -- References -- 13: How to Treat Food Addiction from a Nutritional Perspective: Consideration of Diet and Abstinence. 13.1 Nutritional Approaches and Consideration of Abstinence -- 13.2 Related Tips -- 13.2.1 Increase Satiety and Brain Health-Promoting Foods -- 13.2.2 Do Not Over-restrict Calorie Intake -- 13.2.3 Realize that Craving Will Diminish with Time in Recovery -- 13.2.4 Abstinence Is Not Absolute: Avoid All-or-Nothing Thinking -- 13.2.5 Is It Better to Start More Extreme or Use a Graded Approach During Initiation? -- 13.2.6 Track Progress -- 13.3 How to Incorporate FA Treatment into ED Treatment Programming -- 13.4 What to Do with "Normal Weight" FA Patients? -- 13.5 Conclusion -- References -- 14: Clinical Applications of the Food Addiction Concept -- 14.1 Treatment Overview -- 14.2 Supplemental Programmatic Elements Which Might Be Useful for Treatment of FA -- 14.2.1 Psychoeducation: FA Is a Brain-Based Disorder -- 14.2.2 Psychosocial Interventions -- 14.2.2.1 CBT -- 14.2.2.2 Behavioral Weight Management -- 14.2.2.3 Motivational Interviewing (MI) -- 14.2.2.4 Psychotherapy to Reduce Negative Affect States, Improve Emotion Regulation, and Address Alexithymia -- 14.2.2.5 Mindfulness-Based (MB) Approaches -- 14.2.2.6 Body Image Work -- 14.2.3 Importance of Sleep -- 14.2.4 Importance of Exercise -- 14.2.5 Importance of Getting Psychiatric and Psychological Care -- 14.2.6 Neuromodulation Techniques -- 14.2.7 12-Step Programs and Other Support -- 14.2.8 Medications -- 14.2.9 Bariatric Surgery -- 14.3 Subtyping and FA Treatment Matching -- 14.3.1 Within-FA Treatment Matching -- 14.3.2 Using FA as a Treatment Matching Variable for Patients with Obesity and BE -- 14.4 Conclusion -- References -- Part VI: Research Possibilities -- 15: Emerging Treatments and Areas for Future Research -- 15.1 Emerging Treatments for Disordered Eating -- 15.1.1 Neurostimulation -- 15.1.2 Real-Time fMRI (Rt-fMRI) Neurofeedback Training. 15.1.3 Cognitive Training. |
| Record Nr. | UNINA-9910502621703321 |
Wilcox Claire E.
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Obesity
| Obesity |
| Pubbl/distr/stampa | Silver Spring, Md., : NAASO, The Obesity Society, ©2006- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Obesity
Obésité Obesitat |
| Soggetto genere / forma |
Periodical
Internet resource periodicals. Periodicals. Périodiques. Revistes electròniques. |
| ISSN | 1930-739X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910143461103321 |
| Silver Spring, Md., : NAASO, The Obesity Society, ©2006- | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Obesity science & practice
| Obesity science & practice |
| Pubbl/distr/stampa | [Hoboken, New Jersey] : , : John Wiley & Sons Inc., , [2015]- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.398 |
| Soggetto topico |
Obesity
Obesitat Nutrició |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| Soggetto non controllato | Metabolic & Nutritional Diseases |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Obesity science and practice |
| Record Nr. | UNISA-996200355203316 |
| [Hoboken, New Jersey] : , : John Wiley & Sons Inc., , [2015]- | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Obesity science & practice
| Obesity science & practice |
| Pubbl/distr/stampa | [Hoboken, New Jersey] : , : John Wiley & Sons Inc., , [2015]- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.398 |
| Soggetto topico |
Obesity
Obesitat Nutrició |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Obesity science and practice |
| Record Nr. | UNINA-9910134946103321 |
| [Hoboken, New Jersey] : , : John Wiley & Sons Inc., , [2015]- | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Obesity surgery
| Obesity surgery |
| Pubbl/distr/stampa | [Oxford], : Rapid Science Publishers, 1991- |
| Disciplina | 573.3 |
| Soggetto topico |
Obesity - Surgery
Obesity, Morbid - surgery Obésité - Chirurgie Obesitat |
| Soggetto genere / forma |
Periodical
Periodicals. Llibres electrònics. |
| ISSN | 1708-0428 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Obes surg |
| Record Nr. | UNINA-9910142680603321 |
| [Oxford], : Rapid Science Publishers, 1991- | ||
| Lo trovi qui: Univ. Federico II | ||
| ||